Sign Up to like & get
recommendations!
0
Published in 2019 at "Nature Biomedical Engineering"
DOI: 10.1038/s41551-019-0375-6
Abstract: Checkpoint blockade therapy targeting the programmed-death ligand 1 (PD-L1) and its receptor programmed cell death 1 promotes T-cell-mediated immunosurveillance against tumours, and has been associated with marked clinical benefit in cancer patients. Antibodies against PD-L1…
read more here.
Keywords:
palmitoylation;
enhances cell;
inhibiting palmitoylation;
palmitoylation enhances ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Hepatology Research"
DOI: 10.1111/hepr.13404
Abstract: Hepatocytes can proliferate and regenerate when injured by toxins, viral infections, and so on. Augmenter of liver regeneration (ALR) is a key regulator of liver regeneration, but the mechanism is unknown. The role of ALR…
read more here.
Keywords:
augmenter liver;
enhances cell;
cell proliferation;
liver regeneration ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Blood"
DOI: 10.1182/blood.2020009081
Abstract: Venetoclax, a Bcl-2 inhibitor, in combination with the hypomethylating agent, Azacytidine, achieves complete response with or without count recovery in approximately 70% of treatment-naïve elderly patients unfit for conventional intensive chemotherapy. However, the mechanism of…
read more here.
Keywords:
venetoclax;
cell mediated;
enhances cell;
venetoclax enhances ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Diabetes"
DOI: 10.2337/db21-0681
Abstract: Double C2 Domain Β (DOC2b) protein is required for glucose-stimulated insulin secretion (GSIS) in β-cells, the underlying mechanism of which remains unresolved. Our biochemical analysis using primary human islets, human and rodent clonal β-cells revealed…
read more here.
Keywords:
doc2b;
gsis;
enhances cell;
mechanism ... See more keywords